By Dean Seal

Moderna Inc. said Friday that the European Medicines Agency is formally recommending the use of the company's Covid-19 booster shot for adolescents in the European Union.

The regulator's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending Moderna's Spikevax booster for people between the ages of 12 and 17.

The agency said the booster should come at least three months after completion of the primary vaccine series.

Moderna's chief executive, Stéphane Bancel, said the company is looking ahead for an authorization decision from the European Commission.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

July 22, 2022 08:43 ET (12:43 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Moderna Charts.